HomeIBT-B • STO
add
Infant Bacterial Therapeutics AB
Previous close
kr 48.80
Day range
kr 44.90 - kr 48.90
Year range
kr 21.70 - kr 135.00
Market cap
594.93M SEK
Avg Volume
28.76K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 33.82M | 0.12% |
Net income | -32.65M | -5.70% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 226.20M | -38.40% |
Total assets | 239.30M | -38.12% |
Total liabilities | 35.28M | -13.26% |
Total equity | 204.03M | — |
Shares outstanding | 13.47M | — |
Price to book | 3.22 | — |
Return on assets | -31.56% | — |
Return on capital | -38.37% | — |
Cash Flow
Net change in cash
(SEK) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -32.65M | -5.70% |
Cash from operations | -50.60M | -72.65% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -46.32M | -169.91% |
Free cash flow | -34.80M | -74.54% |
About
Founded
2011
Website
Employees
10